Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.126
+0.011 (1.00%)
Mar 2, 2026, 2:49 PM EST - Market open
Humacyte Stock Forecast
HUMA's stock price has decreased by -67.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Humacyte stock have an average target of 10, with a low estimate of 3.00 and a high estimate of 25. The average target predicts an increase of 787.94% from the current stock price of 1.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,119.85% | Feb 19, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +432.77% | Feb 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,119.85% | Feb 9, 2026 |
| Benchmark | Benchmark | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +787.94% | Jan 21, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +2,119.85% | Jan 8, 2026 |
Financial Forecast
Revenue This Year
2.88M
Revenue Next Year
23.95M
from 2.88M
Increased by 731.05%
EPS This Year
-0.31
from -1.26
EPS Next Year
-0.46
from -0.31
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.9M | 46.9M | ||||
| Avg | 2.9M | 24.0M | ||||
| Low | 2.1M | 10.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 1,526.0% | ||||
| Avg | - | 731.1% | ||||
| Low | - | 275.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.19 | -0.36 | ||||
| Avg | -0.31 | -0.46 | ||||
| Low | -0.57 | -0.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.